<?xml version="1.0" encoding="UTF-8"?>
<p id="p0395">It must be taken into account that transfusion-transmitted SARS-CoV-2, acute transfusion-related injuries, other transfusion-transmissible infections, transfusion-associated circulatory overload, and allergic transfusion reactions could be risks of plasma therapy in the treatment of COVID-19 
 <xref rid="b0735" ref-type="bibr">[147]</xref>, 
 <xref rid="b0740" ref-type="bibr">[148]</xref>.
</p>
